Optipharm.CO.,LTD Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	22,345	19,636	17,373	16,008	14,258
Other Revenue	-0	-0	-	-	-0
Revenue	22,345	19,636	17,373	16,008	14,258
Revenue Growth (YoY)	13.79%	13.03%	8.52%	12.27%	9.29%
Cost of Revenue	16,757	14,741	13,177	12,293	10,522
Gross Profit	5,587	4,896	4,195	3,715	3,736
Selling, General & Admin	4,447	3,946	3,301	2,546	2,729
Research & Development	2,821	2,802	2,946	2,632	5,022
Amortization of Goodwill & Intangibles	22.86	22.83	22.56	22.05	25.3
Other Operating Expenses	268.99	187.32	184.01	363.43	118.5
Operating Expenses	8,001	7,348	6,826	5,904	8,241
Operating Income	-2,414	-2,452	-2,631	-2,188	-4,505
Interest Expense	-504.07	-544.33	-477.34	-353.51	-173.78
Interest & Investment Income	372.71	598.82	665.39	464.38	234.2
Earnings From Equity Investments	-	-	-1.49	-0.35	-0.29
Currency Exchange Gain (Loss)	-1.67	0.02	0.12	-1.38	-3.48
Other Non Operating Income (Expenses)	64.1	39.74	6.52	31.2	1,370
EBT Excluding Unusual Items	-2,483	-2,358	-2,438	-2,048	-3,078
Gain (Loss) on Sale of Assets	-16.24	0.97	1.06	3.31	-1.76
Pretax Income	-2,499	-2,357	-2,437	-2,045	-3,080
Net Income	-2,499	-2,357	-2,437	-2,045	-3,080
Net Income to Common	-2,499	-2,357	-2,437	-2,045	-3,080
Shares Outstanding (Basic)	15	15	15	15	15
Shares Outstanding (Diluted)	15	15	15	15	15
Shares Change (YoY)	0.44%	-0.22%	0.45%	0.54%	0.66%
EPS (Basic)	-170.00	-161.00	-166.10	-140.00	-212.00
EPS (Diluted)	-170.00	-161.00	-166.10	-140.00	-212.00
Free Cash Flow	-4,062	-2,273	-3,395	-6,968	-2,695
Free Cash Flow Per Share	-276.27	-155.29	-231.40	-477.10	-185.50
Gross Margin	25.01%	24.93%	24.15%	23.21%	26.20%
Operating Margin	-10.80%	-12.49%	-15.14%	-13.67%	-31.59%
Profit Margin	-11.19%	-12.00%	-14.03%	-12.77%	-21.60%
Free Cash Flow Margin	-18.18%	-11.58%	-19.54%	-43.53%	-18.90%
EBITDA	-739.92	-837.6	-1,198	-1,068	-3,429
EBITDA Margin	-3.31%	-4.27%	-6.89%	-6.67%	-24.05%
D&A For EBITDA	1,674	1,614	1,433	1,120	1,076
EBIT	-2,414	-2,452	-2,631	-2,188	-4,505
EBIT Margin	-10.80%	-12.49%	-15.14%	-13.67%	-31.59%
Advertising Expenses	27.81	31.26	28.73	92.55	22.55

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.